All lobbying filings
PROFESSIONAL COMPOUNDING CENTERS OF AMERICA
Lobbying for PROFESSIONAL COMPOUNDING CENTERS OF AMERICA
Filing
1st Quarter - Report
Lobbying activity
3
Issues related to implementation of the Drug Quality and Security Act, issues related to animal drug compounding, issues relating to opioid safety; issues related to the pharmaceutical supply chain; issues related to drug shortages; H.R. 5316, the Drug Shortage Compounding Patient Access Act of 2025; S. 3794 / H.R. 6509, The Safe Drugs Act; S. 3788, The Clear Labels Act
Issues related to Medicare coverage of compounded medications, Drug shortages and Medicare reimbursement for compounded medications, pharmacy direct and indirect remuneration fees
Agriculture appropriations spending bill; Department of Labor-Health and Human Services appropriations bill